Atlas Trials

Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Clinical trial NCT00477750 · COMPLETED

Trial details

NCT number
NCT00477750
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma and Plasma Cell Neoplasm
Start date
2005-06-01
Primary completion
2008-04-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.